MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ
538.23
+2.73
+0.51%
After Hours: 538.23 0 0.00% 16:10 07/10 EDT
OPEN
536.31
PREV CLOSE
535.50
HIGH
540.37
LOW
530.07
VOLUME
177.54K
TURNOVER
--
52 WEEK HIGH
628.92
52 WEEK LOW
306.70
MARKET CAP
15.37B
P/E (TTM)
33.86
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-TD Cowen sees improving demand for contract research firms in Q2 2026
Reuters · 2d ago
Dollar Tree upgraded, PayPal initiated: Wall Street’s top analyst calls
TipRanks · 2d ago
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Benzinga · 2d ago
Medpace Holdings Price Target Raised to $547.00/Share From $477.00 by Baird
Dow Jones · 3d ago
Medpace Holdings Cut to Neutral From Outperform by Baird
Dow Jones · 3d ago
Baird Downgrades Medpace Holdings to Neutral, Raises Price Target to $547
Benzinga · 3d ago
Medpace downgraded to Neutral from Outperform at Baird
TipRanks · 3d ago
Can Medpace Holdings (MEDP) Justify Its Valuation On Backlog Quality Concerns?
Simply Wall St · 3d ago
More
About MEDP
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Webull offers Medpace Holdings Inc stock information, including NASDAQ: MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.